Polypeptides useful in the preparation of vaccine compositions against RSV are provided. Also disclosed are methods of enhancing subdominant antibody responses in a subject.
Type
patent
EPO Family ID
67137529
Note
Alternative title(s) : (de) Immunogen (fr) Immunogène
TTO classification
TTO:6.2010
| Identifier | Country code | Kind code | Date issued |
JP2022542003 | JP | A | 2022-09-29 |
US2022249649 | US | A1 | 2022-08-11 |
EP3758004 | EP | A1 | 2020-12-30 |
CA3145336 | CA | A1 | 2020-12-30 |
WO2020260910 | WO | A1 | 2020-12-30 |
Available on Infoscience
January 4, 2021
Use this identifier to reference this record